Page 124 - Aet News Today

While the average lifespan for Americans is 77.9 years, Americans are living only 65.9 years in good health. A new Deloitte report shows that if changes are made, Americans’ average lifespan could reach 90 years by 2040, with 85 of those years being in good health.

Renee Dua and Nick Desai —the husband-and-wife duo who founded physician house call company Heal in 2014 — have launched another healthcare startup. The company, called Together by Renee, said it is the first app to use generative AI to manage time-consuming healthcare tasks for older patients, those with chronic diseases and their stressed-out caregivers.

Arcellx attributes the death to limitations of the treatments that patients receive while their cell therapies are being manufactured. The company is working to expand these so-called bridging therapy options for patients.

HC3 recently warned healthcare providers about a "relatively unknown" ransomware gang named TimisoaraHackerTeam. The group leverages legitimate software tools like Microsoft’s BitLocker and Jetico’s BestCrypt to deliver its malware.

A new startup named Zuri Fertility recently launched. Its platform provides resources for patients who are trying to conceive — including telehealth, at-home testing, prescriptions, mental health services, education and care coordination.

Highmark Health has been launching a series of initiatives to support the "food as medicine" movement, including a program that provides some West Virginia residents with debit cards to purchase healthy food at Dollar General stores.

Biosimilars represent an important therapeutic option in modern healthcare, offering cost-effective alternatives to complex biological drugs. The educational gap among healthcare professionals poses a challenge to their widespread adoption. Medical Affairs teams in the pharmaceutical industry are at the forefront of bridging this gap

In order to gain trust from communities, healthcare leaders will need more training on effective communication, said Dr. Vin Gupta, a pulmonologist and chief medical officer of Amazon Pharmacy. He made these comments last week during a panel at the AHIP 2023 conference in Portland.

The FDA approved Roche’s Columvi as a third-line treatment for a type of blood cancer called diffuse large B-cell lymphoma. This new Roche drug will compete against Epkinly, AbbVie’s recently approved DLBCL drug.

To increase your return on technology investment, start with an audit of existing technology. Where is it falling short? Do problems stem from lack of functionality or troubles with adoption? What do all users think?